ResearcherCatholic University of KoreaActive in the last 2 years
In-Ho Kim
Matched on ORCID iD 0000-0002-0351-2074; OpenAlex author ID A5100649695. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2021: 2 papers · 2022: none · 2023: 2 papers · 2024: none · 2025: 1 paper
Papers 5
- Clinical and Molecular Characteristics of KRAS Codon-Specific Mutations in Advanced Pancreatic Ductal Adenocarcinoma with Prognostic and Therapeutic Implicatio… Co-author DOI 10.3390/ijms262210908↗
- Clinical significance of serum-derived exosomal PD-L1 expression in patients with advanced pancreatic cancer. Last author DOI 10.1186/s12885-023-10811-8↗
- Clinicopathological Features and Prognosis of Resected Pancreatic Ductal Adenocarcinoma Patients with Claudin-18 Overexpression. Co-author DOI 10.3390/jcm12165394↗
- Clinical significance of skeletal muscle density and sarcopenia in patients with pancreatic cancer undergoing first-line chemotherapy: a retrospective observat… Co-author DOI 10.1186/s12885-020-07753-w↗
- Neutrophil-to-lymphocyte ratio and carbohydrate antigen 19-9 as prognostic markers for advanced pancreatic cancer patients receiving first-line chemotherapy. Co-author DOI 10.4251/wjgo.v13.i8.915↗
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Myung Ah Lee · 5 shared papers, 2021–2025 · strength 0.99
- Paper Clinical and Molecular Characteristics of KRAS Codon-Specific Mutations in Advanced Pancreatic Ductal Adenocarcinoma wi… DOI 10.3390/ijms262210908↗
- Paper Clinical significance of serum-derived exosomal PD-L1 expression in patients with advanced pancreatic cancer. DOI 10.1186/s12885-023-10811-8↗
- Paper Clinicopathological Features and Prognosis of Resected Pancreatic Ductal Adenocarcinoma Patients with Claudin-18 Overex… DOI 10.3390/jcm12165394↗
- Tae Ho Hong · 4 shared papers, 2021–2025 · strength 0.84
- Paper Clinical and Molecular Characteristics of KRAS Codon-Specific Mutations in Advanced Pancreatic Ductal Adenocarcinoma wi… DOI 10.3390/ijms262210908↗
- Paper Clinical significance of serum-derived exosomal PD-L1 expression in patients with advanced pancreatic cancer. DOI 10.1186/s12885-023-10811-8↗
- Paper Clinicopathological Features and Prognosis of Resected Pancreatic Ductal Adenocarcinoma Patients with Claudin-18 Overex… DOI 10.3390/jcm12165394↗
- Kabsoo Shin · 4 shared papers, 2021–2025 · strength 0.82
- Paper Clinical and Molecular Characteristics of KRAS Codon-Specific Mutations in Advanced Pancreatic Ductal Adenocarcinoma wi… DOI 10.3390/ijms262210908↗
- Paper Clinical significance of serum-derived exosomal PD-L1 expression in patients with advanced pancreatic cancer. DOI 10.1186/s12885-023-10811-8↗
- Paper Clinicopathological Features and Prognosis of Resected Pancreatic Ductal Adenocarcinoma Patients with Claudin-18 Overex… DOI 10.3390/jcm12165394↗
- Se Jun Park · 4 shared papers, 2021–2025 · strength 0.82
- Paper Clinical and Molecular Characteristics of KRAS Codon-Specific Mutations in Advanced Pancreatic Ductal Adenocarcinoma wi… DOI 10.3390/ijms262210908↗
- Paper Clinical significance of serum-derived exosomal PD-L1 expression in patients with advanced pancreatic cancer. DOI 10.1186/s12885-023-10811-8↗
- Paper Clinicopathological Features and Prognosis of Resected Pancreatic Ductal Adenocarcinoma Patients with Claudin-18 Overex… DOI 10.3390/jcm12165394↗
- Dongwoo Cho · 1 shared paper, 2025 · strength 0.26
- Ja Hee Suh · 1 shared paper, 2023 · strength 0.20
- Moon Hyung Choi · 1 shared paper, 2021 · strength 0.17
- In Seok Lee · 1 shared paper, 2021 · strength 0.17
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.